Medpace Holdings, Inc.

NASDAQ:MEDP

342.89 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q1
Revenue 528.104511.044498.401492.499460.868434.074394.098383.744351.207330.947308.552295.567278.293259.965259.678230.373204.995230.879229.886216.238214.104200.741192.115179.253170.144163.077112.682110.643106.216106.611108.243107.799105.95499.58696.04192.13187.85483.03377.929
Cost of Revenue 381.501355.902361.595359.306336.551303.885278.367264.71252.211232.27220.568208.474203.642181.538176.826156.214148.358165.801167.187152.07150.312145.703131.133123.996116.676117.25468.80365.10663.61963.93563.94164.20862.55558.76754.57952.25649.70246.12846.438
Gross Profit 146.603155.142136.806133.193124.317130.189115.731119.03498.99698.67787.98487.09374.65178.42782.85274.15956.63765.07862.69964.16863.79255.03860.98255.25753.46845.82343.87945.53742.59742.67644.30243.59143.39940.81941.46239.87538.15236.90531.491
Gross Profit Ratio 0.2780.3040.2740.270.270.30.2940.310.2820.2980.2850.2950.2680.3020.3190.3220.2760.2820.2730.2970.2980.2740.3170.3080.3140.2810.3890.4120.4010.40.4090.4040.410.410.4320.4330.4340.4440.404
Reseach & Development Expenses 000000000000000000000000000000000000000
General & Administrative Expenses 0041.01400032.10100026.46400025.1240025.12421.26129.1223.55621.30820.56918.60620.50715.99916.84216.60614.75515.15416.78300017.8550000
Selling & Marketing Expenses 001.50001.30001.2000-2.7430000.70000.80000.60000.60000.40000
SG&A 41.45344.08142.51441.40739.40438.02733.40135.41833.21529.36627.66428.04626.97325.73822.38122.79621.85525.12421.26129.1223.55621.30820.56918.60620.50715.99916.84216.60614.75515.15416.78316.39114.82413.50918.25515.29511.70611.74210.203
Other Expenses -0.1334.5933.472-1.6026.525.9585.8995.7895.5455.1081.0891.0640.2650.924-0.2570.5840.2390.617-0.289-0.273-0.019-0.2820.2530.4820.478-0.1530.288-0.145-0.125-0.3720.896-0.378-0.006-0.9351.1020.05-0.002-0.9761.327
Operating Expenses 41.45351.07349.48648.28545.92443.98539.341.20738.7634.47433.12933.3832.20330.82827.86427.73726.50929.57426.58134.17728.53329.14330.31628.33930.12325.70428.44228.33926.31826.73231.41230.97429.28527.9533.03832.6830.28530.51617.234
Operating Income 105.15104.06987.3284.90878.39386.20476.43177.82760.23664.20354.85553.71342.44847.59954.98846.42230.12835.50436.11829.99135.25925.89530.66626.91823.34520.11915.43717.19816.27915.94412.8912.61714.11412.8696.62410.5957.8676.3891.837
Operating Income Ratio 0.1990.2040.1750.1720.170.1990.1940.2030.1720.1940.1780.1820.1530.1830.2120.2020.1470.1540.1570.1390.1650.1290.160.150.1370.1230.1550.1740.1720.170.1350.1330.1520.1470.0770.130.1020.0840.024
Total Other Income Expenses Net 5.3328.7133.387-1.707-2.649-0.174-2.7864.0651.7631.1211.0661.0230.2380.91-0.2860.5680.2340.9740.099-0.526-0.767-1.237-1.346-1.459-1.83-2.462-1.763-2.051-1.933-2.166-12.664-5.034-5.927-6.908-14.265-10.087-6.904-8.049-11.207
Income Before Tax 110.482112.78290.70783.20175.74486.0373.64581.89261.99965.32455.92154.73642.68648.50954.70246.9930.36236.47836.21729.46534.49224.65829.3225.45921.51517.65713.67415.14714.34613.7780.2267.5838.1875.961-7.6410.5080.963-1.66-0.222
Income Before Tax Ratio 0.2090.2210.1820.1690.1640.1980.1870.2130.1770.1970.1810.1850.1530.1870.2110.2040.1480.1580.1580.1360.1610.1230.1530.1420.1260.1080.1370.1530.1520.1470.0020.080.0880.068-0.0890.0060.013-0.022-0.003
Income Tax Expense 22.13110.19112.40912.65114.67613.1364.97515.86512.6394.0135.8876.1622.7525.2033.8365.536.2587.5246.4045.4887.0375.466.5596.1544.9473.1062.3835.3164.7935.3310.2472.5473.2252.5130.9350.6410.8681.6011.014
Net Income 88.351102.54678.24570.50261.02772.84568.62565.98349.32961.27549.99548.42339.80743.16650.65941.32524.03928.87829.73323.91227.37719.14222.67419.22916.50114.49111.2439.8159.5538.435-0.0215.0364.9623.448-8.576-0.1330.095-0.059-1.236
Net Income Ratio 0.1670.2010.1570.1430.1320.1680.1740.1720.140.1850.1620.1640.1430.1660.1950.1790.1170.1250.1290.1110.1280.0950.1180.1070.0970.0890.1130.0990.1010.09-00.0530.0540.039-0.1-0.0020.001-0.001-0.016
EPS 2.853.322.552.322.352.22.131.521.751.391.351.111.211.421.160.680.80.820.670.760.540.640.540.460.410.310.250.240.21-0.0010.140.150.11-0.27-0.0040.003-0.002-0.031
EPS Diluted 2.753.22.462.221.932.272.112.051.461.691.321.291.061.141.341.090.640.760.790.630.730.510.610.520.450.40.290.250.230.2-0.0010.130.150.11-0.27-0.0040.003-0.002-0.031
EBITDA 112.385111.06196.4990.18483.6392.16282.3389.26568.09269.31160.3259.04747.67852.68960.47151.36334.78239.95441.43834.77540.21733.44840.66637.13333.43929.67127.32528.78627.71727.1528.41526.82228.56926.37513.68924.6326.44424.18722.615
EBITDA Ratio 0.2130.2170.1940.1830.1810.2120.2090.2330.1940.2090.1950.20.1710.2030.2330.2230.170.1730.180.1610.1880.1670.2120.2070.1970.1820.2420.260.2610.2550.2630.2490.270.2650.1430.2670.3010.2910.29